AJTMH Tropical Medicine and Hygiene News
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am. J. Trop. Med. Hyg., 53(3), 1995, pp. 303-305
Copyright © 1995 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, S.
Right arrow Articles by Marsh, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, S.
Right arrow Articles by Marsh, K.

Parasite Viability during Treatment of Severe Falciparum Malaria: Differential Effects of Artemether and Quinine

S. Murphy, W. M. Watkins, P. G. Bray, B. Lowe, P. A. Winstanley, N. Peshu AND K. Marsh
Kenya Medical Research Institute, Kilifi Research Unit, Kilifi, Kenya; Wellcome Trust Research Laboratories, Nairobi, Kenya; Department of Pharmacology, University of Liverpool, Liverpool, United Kingdom; Department of Parasitology, Liverpool School of Tropical Medicine, Liverpool, United Kingdom; Nuffield Department of Medicine, John Radcliffe Hospital, Oxford, United Kingdom

The effect of artemether (AR) and quinine (QN) on parasite viability ex vivo was compared in children being treated for severe Plasmodium falciparum malaria. Parasitized blood taken at intervals during treatment was cultured in vitro, and parasite development was assessed microscopically. Parasite viability (defined as the proportion of circulating rings developing to early schizonts) was 56.8% in the AR group (n = 7) 6 hr after the start of treatment, compared with 93.3% for QN (n = 6; P = 0.015). Even after 24 hr of QN treatment, parasite viability was not significantly reduced in five patients. These ex vivo findings, which confirm previous observations of the stage-specific effects of these drugs against P. falciparum, suggest that AR may be superior to QN in the treatment of severe malaria.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Society of Tropical Medicine and Hygiene.